9999999997-15-014862.txt : 20151201 9999999997-15-014862.hdr.sgml : 20151201 20151124115208 ACCESSION NUMBER: 9999999997-15-014862 CONFORMED SUBMISSION TYPE: CT ORDER PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20151201 DATE AS OF CHANGE: 20151124 20151201 20151124 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Strongbridge Biopharma plc CENTRAL INDEX KEY: 0001634432 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 981130690 STATE OF INCORPORATION: L2 FILING VALUES: FORM TYPE: CT ORDER SEC ACT: 1933 Act SEC FILE NUMBER: 333-206654 FILM NUMBER: 151251626 BUSINESS ADDRESS: STREET 1: 900 NORTHBROOK DRIVE, SUITE 200 CITY: TREVOSE STATE: PA ZIP: 19053 BUSINESS PHONE: (610) 254-9200 MAIL ADDRESS: STREET 1: 900 NORTHBROOK DRIVE, SUITE 200 CITY: TREVOSE STATE: PA ZIP: 19053 FORMER COMPANY: FORMER CONFORMED NAME: Cortendo AB DATE OF NAME CHANGE: 20150219 CT ORDER 1 filename1.pdf begin 644 filename1.pdf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